Latest Cost Reduction News

Catalyst Metals has finished mining the Trident open pit at its Plutonic Gold Belt project, enabling underground development expected to produce about 60,000 ounces annually from 2027. This milestone supports Catalyst's strategy to double gold output by developing multiple underground mines feeding a central processing plant.

Regis Resources Ltd (ASX:RRL) and Vault Minerals Ltd (ASX:VAU) have agreed to merge via a scheme of arrangement, forming a new senior gold producer with over 700,000 ounces annual production and a market cap near A$10.7 billion.

ImpediMed has secured A$15.2 million through a two-tranche placement and share purchase plan, alongside A$5 million in cost reductions, aiming for operating cashflow breakeven by H2 FY28.

Endeavour Group posts modest sales gains in Retail and Hotels for Q3 F26 while bracing for supply chain pressures from Middle East tensions and launching a $100 million cost reduction drive.

Temas Resources has appointed VECTOR Advisors to enhance its investor relations amid ongoing development of its Regenerative Chloride Leach technology and critical minerals projects in Quebec.

Experience Co has finalised the sale of its Wild Bush Luxury portfolio for $5.1 million, using the proceeds to reduce corporate debt as it sharpens its focus on scalable adventure tourism.

ANZ Group Holdings Limited posted a 14% rise in cash profit for 1H26 to AUD 3.78 billion, driven by cost reductions and steady revenue, while declaring an 83-cent interim dividend with 75% franking.

Zimi Limited posted 14% revenue growth and landed its biggest project order to date with Homecorp, while slashing operating costs and launching an AI sales agent.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

Australian Strategic Materials reports a 70% surge in NdFeB alloy production, installs pilot heavy rare earth furnace, and progresses its acquisition by Energy Fuels with regulatory approvals underway.

ImpediMed reported a $3.5 million revenue in Q3 FY26, with reimbursement coverage in the US reaching 94.3%, supporting growth in heart health and weight management markets. New CEO Erik Anderson aims to accelerate commercial momentum and drive cash flow break-even.

Boss Energy has trimmed its FY26 uranium production guidance due to severe weather disruptions at its Honeymoon project, while advancing a new feasibility study targeting cost reductions with wide-spaced wellfields.